Medtech Radar 2025: EU’s MDR Woes – Paying The Price For ‘Fixing It When It Ain’t Even Broke’

ZS principal Brian Chapman tells In Vivo what is troubling the global medtech industry at the turn of 2025, and takes the opportunity to chide the EU for its persistent fixation on taking on the “problem that did not need to be solved.”